- Home
- GNFT vs III Comparison
GNFT vs III Comparison
Compare GNFT & III Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- III
- Stock Information
- Founded
- GNFT 1999
- III 2006
- Country
- GNFT France
- III United States
- Employees
- GNFT N/A
- III N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- III Professional Services
- Sector
- GNFT Health Care
- III Consumer Discretionary
- Exchange
- GNFT Nasdaq
- III Nasdaq
- Market Cap
- GNFT 172.2M
- III 178.1M
- IPO Year
- GNFT 2019
- III 2007
- Fundamental
- Price
- GNFT $3.47
- III $3.20
- Analyst Decision
- GNFT Strong Buy
- III Buy
- Analyst Count
- GNFT 1
- III 1
- Target Price
- GNFT $13.00
- III $3.75
- AVG Volume (30 Days)
- GNFT 6.9K
- III 120.9K
- Earning Date
- GNFT 09-19-2024
- III 03-06-2025
- Dividend Yield
- GNFT N/A
- III 5.63%
- EPS Growth
- GNFT N/A
- III N/A
- EPS
- GNFT 0.47
- III N/A
- Revenue
- GNFT $86,225,222.00
- III $255,994,000.00
- Revenue This Year
- GNFT $145.20
- III N/A
- Revenue Next Year
- GNFT N/A
- III N/A
- P/E Ratio
- GNFT $7.23
- III N/A
- Revenue Growth
- GNFT 175.45
- III N/A
- 52 Week Low
- GNFT $3.33
- III $2.92
- 52 Week High
- GNFT $6.42
- III $4.82
- Technical
- Relative Strength Index (RSI)
- GNFT 31.89
- III 42.91
- Support Level
- GNFT $3.35
- III $3.01
- Resistance Level
- GNFT $3.57
- III $3.30
- Average True Range (ATR)
- GNFT 0.11
- III 0.10
- MACD
- GNFT 0.01
- III -0.00
- Stochastic Oscillator
- GNFT 21.82
- III 43.18
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About III Information Services Group Inc.
Information Services Group Inc is a U.S.-based technology insight, market intelligence, and advisory services firm. It principally offers digital transformation services, such as automation and cloud & data analytics; managed governance; network carrier services; technology plan and operations design; changes management; market intelligence & technology research and analysis. It operates in one segment, fact-based sourcing advisory services. Its geographical segments are the Americas, Europe, and Asia-pacific, out of which maximum revenue is derived from Americas.